PIRARUBICIN for Transcatheter arterial chemoembolisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 5 adverse event reports in the FDA FAERS database where PIRARUBICIN was used for Transcatheter arterial chemoembolisation.

Most Reported Side Effects for PIRARUBICIN

Side Effect	Reports	%	Deaths	Hosp.
Myelosuppression	408	30.3%	5	260
White blood cell count decreased	207	15.4%	9	114
Neutrophil count decreased	145	10.8%	3	90
Bone marrow failure	127	9.4%	14	55
Nausea	111	8.2%	2	68
Vomiting	104	7.7%	2	70
Gastrointestinal disorder	58	4.3%	1	39
Leukopenia	55	4.1%	0	21
Pyrexia	55	4.1%	4	36
Neutropenia	54	4.0%	13	18
Febrile neutropenia	53	3.9%	13	16
Decreased appetite	50	3.7%	7	20
Platelet count decreased	43	3.2%	6	21
Anaemia	42	3.1%	6	13
Hepatic function abnormal	41	3.0%	3	11